Literature DB >> 1329517

Phenotype of villous stromal cells in placentas with cytomegalovirus, syphilis, and nonspecific villitis.

M A Greco1, R Wieczorek, R Sachdev, C Kaplan, G J Nuovo, R I Demopoulos.   

Abstract

Villous stromal cells (VSC) play an important role in fetomaternal placental immune function. We studied the phenotype of VSC in infection by cytomegalovirus (CMV) and syphilis as well as nonspecific villitis and compared the findings with gestational age-matched controls. Monoclonal antibodies directed against total leukocytes, T cells, B cells, macrophages, dendritic cells, granulocytes and HLA-DR as well as polyclonal antibodies against S-100, alpha-1 antichymotrypsin, and lysozyme were used. In controls, the immunocytochemical response for each marker was either negative or weakly positive. In contrast, the VSC in CMV-infected and nonspecific villitis showed intense reactivity to various macrophage markers. In syphilis, reactivity with macrophage markers such as lysozyme and MAC387 were weaker, and reactivity to HLA-DR and S-100 was much stronger. Endothelial cells strongly expressed the monocyte/granulocyte marker CD15 in the diseased states, especially in syphilis, relative to controls. We conclude that the phenotype of VSC is altered in disease states and that the changes are dependent to some degree on the specific subset of chronic villitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329517      PMCID: PMC1886623     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Recruitment of neutrophils in the local endotoxin response: association with de novo endothelial expression of endothelial leukocyte adhesion molecule-1.

Authors:  J M Munro; J S Pober; R S Cotran
Journal:  Lab Invest       Date:  1991-02       Impact factor: 5.662

Review 2.  The human placental villitides: a review of chronic intrauterine infection.

Authors:  G Altshuler; P Russell
Journal:  Curr Top Pathol       Date:  1975

3.  Immunohistochemical study of human placental stromal cells.

Authors:  Y Nakamura; Y Ohta
Journal:  Hum Pathol       Date:  1990-09       Impact factor: 3.466

Review 4.  Integrins and other cell adhesion molecules.

Authors:  S M Albelda; C A Buck
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

5.  Distribution of ICAM-1 within decidua and placenta and its gestational age-associated changes.

Authors:  C M Salafia; N Haynes; V J Merluzzi; R Rothlein
Journal:  Pediatr Pathol       Date:  1991 May-Jun

6.  Immunohistologic evidence that villitis in human normal term placentas is an immunologic lesion.

Authors:  C A Labarrere; J A McIntyre; W P Faulk
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

7.  Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells.

Authors:  G Walz; A Aruffo; W Kolanus; M Bevilacqua; B Seed
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

8.  Chronic villitis of unknown aetiology in recurrent intrauterine fetal growth retardation.

Authors:  C Labarrere; O Althabe
Journal:  Placenta       Date:  1987 Mar-Apr       Impact factor: 3.481

9.  Placental protein distribution in maternal diabetes mellitus: an immunocytochemical study.

Authors:  M A Greco; B R Kamat; R I Demopoulos
Journal:  Pediatr Pathol       Date:  1989

10.  In situ hybridization analysis for cytomegalovirus in chronic villitis.

Authors:  R Sachdev; G J Nuovo; C Kaplan; M A Greco
Journal:  Pediatr Pathol       Date:  1990
View more
  2 in total

1.  Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells.

Authors:  R W Redline; P Patterson
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

2.  Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.

Authors:  M Ittmann; R Wieczorek; P Heller; A Dave; J Provet; J Krolewski
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.